Melanoma Workshop

May 15-17 2019, Otranto, Italy
Pictures of the event, added after the event has passed ...
Event has passed
Corporate Partners
Melanoma Workshop

Melanoma is one of the most aggressive cancers with a rapidly increasing incidence. Although enormous advances have been made over recent years, especially for targeted therapies against activated BRAF or immunotherapies, major barriers remain. Anti-BRAF therapy is effective only for those 50% patients with the BRAF mutation and relapse almost inevitably occurs after a few months. Immunotherapies are variably effective and again, resistance can emerge. Key to delivering more effective therapies for this devastating disease will require a multidisciplinary approach, exploitation of disruptive emerging technologies and close interactions between scientists and clinicians.

In 2009 Prof. Colin Goding of the University of Oxford, UK initiated a melanoma workshop with the aim of promoting both the open discussions of unpublished data and synergistic collaborations. The meeting was subsequently held annually in Nice, Milan, Malmo, Marseille, Las Palmas, Reykjavik, Varenna, Sestri Levante and Israel in 2018. These meetings are renowned for their informal small workshop format where all participants, comprising leading scientists and clinicians, present their most exciting and unpublished work. As such, these meetings are unique in the field and are considered - by all participants - to be the best melanoma meeting in recent years, owing to the degree of openness and the highly collaborative spirit.

The 2019 edition will be held in Otranto, and organized by Chris Marine (lead), Eleonora Leucci, Ze’ev Ronai and Colin Goding. Recent advances in immunotherapy, high-throughput integrative genomics, metabolism, long non-coding RNAs, epigenetics, signaling, animal modeling will be discussed. A session will be dedicated to “emerging technologies” focusing on the contribution of intratumor heterogeneity to melanoma evolution and therapy response.

Speakers:

  • Andrew Aplin - Thomas Jefferson University, US
  • Robert Ballotti - INSERM, FR
  • Corine Bertollotto - INSERM, FR
  • Geert Berx - Ugent Center of Inflammation, BE
  • Genevieve Marie Boland - Massachusets General Hospital, US
  • Anja Bosserhoff - Friedrich-Alexander University, DE
  • Julie Caramel - CRCL, FR
  • Carmit Levy - Tel Aviv University, IL
  • Irwin Davidson - IGBMC, FR
  • Marie-Dominique Galibert - University of Rennes, FR
  • Colin Goding - Ludwig Institute of Cancer Research, University of Oxford, UK
  • Michael Hoelzel - University Hospital Bonn, DE
  • Goran Jonsson - Lund University, SE
  • Florian Karreth - Moffitt Cancer Center, US
  • Luisa Lanfrancone - European Institute of Oncology, IT
  • Lionel Larue - Institut Curie, FR
  • Mitchell Levesque - Department of Dermatology, University of Zurich Hospital, CH
  • Laurence Nieto - IPBS, FR
  • Elizabeth Patton - Edinburgh University, UK
  • Daniel Peeper - Netherlands Cancer Institute, NL
  • Caroline Robert - Gustave Roussy Cancer Center, FR
  • Stéphane Rocchi - University of Nice, FR
  • Ze'ev Ronai - SBP Medical Discovery Institute, US
  • Yardena Samuels - Weizmann Institute of Science, IL
  • Marisol Soengas - CNIO, ES
  • Lukas Sommer - Institute of Anatomy, University of Zurich, CH
  • Eirikur Steingrimsson - University of Iceland Biomedical Center, ISMax Planck Institute for Molecular Genetics / Germany
  • Thomas Tueting - University Hospital Magdeburg, DE
  • Ashani Weeraratna - Melanoma Research Center, The Wistar Institute, US
  • Richard White - Memorial Sloan Kettering Cancer Center, Weill Cornel Medical College, US
  • Marie Laure Yaspo - Max Planck Institute for Molecular Genetics, DE

 

Before you leave

Click here to view some interesting reading material

Day 1 - 15 May 2019

Wednesday, 15 May, 2019
20:30
Dinner “Cala dei normanni”

Organizing committee:

Chris Marine, VIB KULeuven Center for Cancer Biology
Eleonora Leucci, KULeuven Department of Oncology
Colin Goding - Ludwig Institute of Cancer Research, University of Oxford, UK
Ze'ev Ronai - SBP Medical Discovery Institute, US

Day 2 - 16 May 2019

Thursday, 16 May, 2019
08:00 - 09:00
Breakfast
09:00 - 10:45
New insights into Melanoma Biology

Scientific Program (Camelia room) (almost 50% of the speakers are female!)

Colin Goding
Oxford Ludwig Institute, University of Oxford, UK
Anja Bosserhoff
Friedrich-Alexander University Erlangen-Nürnberg, DE
Marisol Soengas
Spanish National Cancer Centre (CNIO), ES
Eirikur Steingrimsson
University of Iceland, IS
Irwin Davidson
IGBMC, FR
Andrew Aplin
Philadelphia University + Thomas Jefferson University, US
10:45 - 11:15
Coffee break
11:15 - 13:00
Animal models
Elizabeth Patton
Edinburgh University, UK
Richard White
Memorial Sloan Kettering Cancer Center, Weill Cornel Medical College, US
Lionel Larue
Institut Curie, FR
Florian Karreth
Moffitt Cancer Center, US
Lukas Sommer
Institute of Anatomy, University of Zurich, CH
Jean-Christophe Marine
VIB-KU Leuven Center for Cancer Biology, BE
13:00 - 14:30
Lunch
14:30 - 16:00
Immune evasion - immunotherapy
Thomas Tueting
University Hospital Magdeburg, DE
Nicole Glodde
Lab for RNA Biology, University Hospital Bonn, DE
Jingjing Zhu
Université Catholique de Louvain - UCLouvain, BE
Daniel Peeper
Netherlands Cancer Institute, NL
Caroline Robert
Institute Gustave Roussy, FR
16:00 - 16:30
Break/drinks
16:30 - 18:15
Immune evasion – immunotherapy II
Osnat Bartok
The Weizmann Institute of Science, IL
Yardena Samuels
Weizmann Institute of Science, IL
Zelenay Santiago
Cancer Research UK Manchester Institute, University of Manchester, UK
Goran Jonsson
Lund University, SE
Ze’ev Ronai
SBP Medical Discovery Institute, US
19:30 - 20:00
Aperitivo
20:00
Gala dinner @ 'The Basiliani'

Entertainment (Singing and dancing) by “Progetto Demotikós”

Organizing committee:

Chris Marine, VIB KULeuven Center for Cancer Biology
Eleonora Leucci, KULeuven Department of Oncology
Colin Goding - Ludwig Institute of Cancer Research, University of Oxford, UK
​Ze'ev Ronai - SBP Medical Discovery Institute, US

Day 3 - 17 May 2019

Friday, 17 May, 2019
08:00 - 09:00
Breakfast
09:00 - 10:45
Emerging technologies for probing magnitude/dynamics of intra-tumor heterogeneity
10:45 - 11:15
Steve Glavas
Celsee
Mission Bio
Gema Fuerte
Mission Bio
Roberto Spada
Fluidigm
Florian Rambow
VIB-KULeuven Center for Cancer Biology, BE
Jasper Wouters
VIB-KU Leuven Center for Brain & Disease Research, BE
10:45 - 11:15
Coffee break
11:15 - 12:45
Genetic versus nongenetic Intratumor Heterogeneity
Dave Adams
Wellcome Sanger Institute
Daniela Robles-Espinoza
LIIGH-UNAM
Antonia Pritchard
University of Highlands and Islands
Robert Ballotti
INSERM, FR
Julie Caramel
CRCL, FR
Geert Berx
Ugent Center of Inflammation, BE
12:45 - 14:15
Lunch
14:15 - 16:30
Resistance to (targeted) therapy
Geneviève Boland
Massachusets General Hospital, US
Marie-Dominique Galibert
University of Rennes, FR
Stephane Rocchi
University of Nice, FR
Luisa Lanfrancone
European Institute of Oncology, IT
Eleonora Leucci
Department of Oncology, KU Leuven, BE
Mitch Levesque
Department of Dermatology, University of Zurich Hospital, CH
16:30
Closing remarks by Colin, Ze’ev & Chris
20:00
Aperitivo & Dinner in Otranto

Organizing committee:

Chris Marine, VIB KULeuven Center for Cancer Biology
Eleonora Leucci, KULeuven Department of Oncology
Colin Goding - Ludwig Institute of Cancer Research, University of Oxford, UK
​Ze'ev Ronai - SBP Medical Discovery Institute, US

Attendees

The full list of attendees will be available on 15-05-2019 until 17-05-2019.
This list will only be available for registered attendees of the event.

Abstracts

The full list of abstracts will be available on 15-05-2019 until 17-05-2019.
Only registered attendees can download abstracts.